Although IL-6 exerts both pro- and anti-inflammatory activities depending on the context [79], chronic low-grade inflammation mediated by IL-6 in the adipose tissue could be related to the progression of NAFLD. Here, IL6 is linked to metabolic dysfunction-associated steatotic liver disease.